Modulim
Irvine, US · Founded 2005 · 8 employees on LinkedIn · 2 known investors
Find your way into Modulim
Sign up to see every warm intro you have to Modulim
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Modulim team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications. The company builds point-of-care medical imaging devices for healthcare providers.
Founders & leadership
Modulim was founded in 2005 by David J. Cuccia.



Investors · 2
How we know: Fresenius Medical Care Ventures's portfolio page · Not right? Tell us
How we know: Pangaea Ventures Us Inc.'s portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.2M |
| Department of DefenseDefense Health Program | Phase ISTTR | 2017 | $146.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $2.2M |
| Department of DefenseDefense Health Program | Phase II | 2012 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $158.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2011 | $1.3M |
| Department of DefenseDefense Health Program | Phase I | 2011 | $149K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $698.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $700K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2006 | $99.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2006 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Modulim do?
- Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications. The company builds point-of-care medical imaging devices for healthcare providers.
- Who founded Modulim?
- Modulim was founded by David J. Cuccia in 2005.
- Who are Modulim's investors?
- Modulim's investors include Fresenius Medical Care Ventures, Pangaea Ventures Us Inc..
- Where is Modulim headquartered?
- Modulim is headquartered in Irvine, US.


